News

Under the agreement, the National Cancer Institute (NCI) will supply Agencourt with normal and cancer tumor tissue samples and periodic lists of genes and targeted regions to be

Treatment with AV-101 was found to increase the ‘firing rate’ and ‘burst firing’ activity of dopaminergic (DA) neurons by 27% and 61%, respectively. These are two key indicators

The National Institute of Neurological Disorders and Stroke granted Cambria a Phase I SBIR award to identify small molecule compounds that protect against cellular damage caused by the

During the experiments, 100% of the ferrets treated with VGX-3400 survived, while 100% of the control animals died. Vaccination with VGX-3400 generated potent neutralizing antibody and cell-mediated immune

These endocrine effects were associated with a significant increase in Fat Free Mass (FFM), and concomitant reduction in Fat Mass (FM) when measured by DEXA scan and bioelectrical

The multi-center studies evaluated the new once-daily formulation of Xibrom versus placebo in over 500 patients who underwent cataract surgery. The highly statistically significant findings demonstrated Xibrom QD

US-based Merck reached an agreement with the executive committee of the plaintiffs’ steering committee of the federal multidistrict Vioxx litigation as well as representatives of plaintiffs’ counsel in

Aureus Pharma’s target-family-based AurSCOPE knowledge databases contain quantitative biological activity data which has been mined from the scientific literature. By understanding existing structure activity relationships, and the overall

BioMarck Pharmaceuticals has licensed worldwide exclusive rights for this patent and related patents from North Carolina State University. The new patent provides broad protection for a series of